Skip to content

Pedometers and Walking Tests for Pulmonary Hypertension Patients

Pedometers and Walking Tests for Pulmonary Hypertension Patients: a First, Prospective Psychology and Concordance Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03810482
Acronym
HTAPODO
Enrollment
70
Registered
2019-01-18
Start date
2019-03-21
Completion date
2024-06-21
Last updated
2023-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Pulmonary

Keywords

health related quality of life, anxiety, depression, coping, fatigue

Brief summary

Concordance between walking tests and pedometer data may seem like a logical outcome for pulmonary hypertension (PH) patients. However, many individuals have discordant results: results much worse or better during an in-hospital walking test as compared to real life activity. The primary objective of this study is: to determine variables associated with discordance between the distance walked during an in-hospital 6-minute walking test (6MWT) and the average distance travelled per day (observed over a period of 28 days (2 × 14 days) using a pedometer) among PH patients.

Detailed description

Secondarily, the discordance between 6MWT results versus total pedometer recorded distance and versus maximum daily pedometer-recorded distance will be similarly studied. The aim of the study is also to search for variables associated with progression free survival. The relationships between pedometer data and self-reported dyspnea variation will be studied. Factorial analysis may be used to study the overall view of variable correlations and patient similarity/dissimilarity.

Interventions

DEVICEPedometer

A pedometer will be worn by the patient at home for days 1 to 14 and 60 to 74.

Performed according to current recommendations during routine visits (baseline and \ 90 days for the purposes of this study).

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

In this first study, the links between variables and discordance between walking test and pedometer results will be searched.

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patient with idiopathic pulmonary hypertension (PH), familial PH, or PH associated with various pathologies (groups I to IV of the international classification) * New York Heart Association (NYHA) severity classes II to IV * Incident cases, or prevalent cases with stable disease over the last 3 months * Collection of informed written consent * Affiliation with or beneficiary of a social security program (health insurance) * Outpatient consulting at the hospital on the day of inclusion * 6 minute walking test on day of inclusion

Exclusion criteria

* Patients protected or unable to give consent according to Article L1121-8 of the French Public Health Code (CSP) * Pregnant or lactating women according to article L1121-5 of the CSP * Vulnerable persons according to article L1121-6 of the CSP * Simultaneous participation in any other research protocol * It is impossible to correctly inform the patient (language barrier, etc.) * The patient has already been included in the study

Design outcomes

Primary

MeasureTime frameDescription
The patient's discordance category as precisely defined here:74 daysLinear regression is performed for the distance walked during an initial 6 minute walking test (6MWT) and the average distance walked per day according to the pedometer intervention. The residuals from this regression will determine categories: Category 1 (pedometer high): the 25% of subjects not in category 2 and with higher values for pedometer data Category 2 (concordance): the 50% of included subjects with the smallest residuals in terms of absolute value. Category 3 (6MWT high): the 25% of subjects not in category 2 and with higher values for 6MWT data

Secondary

MeasureTime frameDescription
Health related quality of life questionnaire (the Medical Outcome Study - Short Form (SF36))Day 0This scale evaluates social, emotional and physical health of the patient through 11 questions.
Hospital Anxiety and Depression (HAD) scaleDay 0It is a questionnaire which detects if the patient is anxious or depressed through 14 questions.
State-Trait Anxiety Inventory (STAI) questionnaireDay 0The State-Trait Anxiety Inventory is a 20 question-scale. For each question 4 levels of response are possible from 1 (never) to 4 (always).
Multidimensional Fatigue Inventory (MFI)-20 questionnaireDay 0This questionnaire assesses the severity of the patient fatigue through 20 questions. For each question, 4 levels of response are possible : from not at all to completely.
Coping with Health Injuries and Problems ScaleDay 0This questionnaire assesses how the patient responds to health injuries and problems with 32 questions. For each question 5 levels of response are possible from 1 (not at all) to 5 (always).

Countries

France

Contacts

Primary ContactLaurence Halimi, PhD, psychologist
l-halimi@chu-montpellier.fr+33.(0)4.67.33.07.45

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026